Immediate Impact
2 standout
Citing Papers
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
2019 Standout
From tumour heterogeneity to advances in precision treatment of colorectal cancer
2016 Standout
Works of L. Mol being referenced
Randomised phase 3 study of S-1 versus capecitabine, with bevacizumab optional in both arms, in the first-line treatment of metastatic colorectal cancer (mCRC), the SALTO study of the Dutch Colorectal Cancer Group
2017
The CAIRO4 Study: The Role of Surgery of the Primary Tumour with Few or Absent Symptoms in Patients with Synchronous Unresectable Metastases of Colorectal Cancer: A Randomized Phase III Study
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| L. Mol | 7 | 5 | 1 | 4 | 7 | ||
| Min-Hee Ryu | 6 | 5 | 1 | 2 | 6 | ||
| Ryan Brennan | 6 | 6 | 3 | 7 | |||
| A. Fernandez Ortega | 2 | 8 | 4 | 1 | 4 | 10 | |
| Angela BY Hui | 5 | 6 | 2 | 8 | |||
| H. Lee | 5 | 4 | 1 | 2 | 8 | ||
| Jesús Alarcón Company | 10 | 4 | 4 | 10 | |||
| Heiko Graf | 7 | 3 | 3 | 7 | |||
| P Shokuhi | 2 | 8 | 3 | 3 | 8 | ||
| Ariane Kemkes | 1 | 5 | 3 | 4 | 7 | ||
| R. Weiss | 3 | 4 | 5 | 2 | 7 |
All Works
Loading papers...